Safety and efficacy of rilpivirine-tenofovir-emtricitabine (Eviplera (R)) in hepatitis C-HIV coinfection

F. Cresswell; A. Gothard; M. Cevik; G. Haidari; H. Alexander; I. Katsarolis; T. McGinty; A. Wolujewic; C. Saxon; M. Phillips; L. Hedley; N. Brima; N. Marshall; L. Swaden; J. Thornhill; A. de Ruiter; R. Nandwani; P. Mallon; M. Chaponda; D. Churchill; M. Kingston; A. Ustianowski; L. Waters; C. Orkin; C. Smith; M. Nelson

Safety and efficacy of rilpivirine-tenofovir-emtricitabine (Eviplera (R)) in hepatitis C-HIV coinfection

F. Cresswell, A. Gothard, M. Cevik, G. Haidari, H. Alexander, I. Katsarolis, T. McGinty, A. Wolujewic, C. Saxon, M. Phillips, L. Hedley, N. Brima, N. Marshall, L. Swaden, J. Thornhill, A. de Ruiter, R. Nandwani, P. Mallon, M. Chaponda, D. ChurchillM. Kingston, A. Ustianowski, L. Waters, C. Orkin, C. Smith, M. Nelson

School of Medicine

Research output: Contribution to journal › Abstract › peer-review

Original language	English
Pages (from-to)	A61-A61
Number of pages	1
Journal	Antiviral therapy
Volume	18
Publication status	Published - 2013
Event	15th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV - Brussels, Belgium Duration: 15 Oct 2013 → 17 Oct 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Handle.net

Persistent link

Cite this

Cresswell, F., Gothard, A., Cevik, M., Haidari, G., Alexander, H., Katsarolis, I., McGinty, T., Wolujewic, A., Saxon, C., Phillips, M., Hedley, L., Brima, N., Marshall, N., Swaden, L., Thornhill, J., de Ruiter, A., Nandwani, R., Mallon, P., Chaponda, M., ... Nelson, M. (2013). Safety and efficacy of rilpivirine-tenofovir-emtricitabine (Eviplera (R)) in hepatitis C-HIV coinfection. Antiviral therapy, 18, A61-A61.

@article{ad1343de1a3b476e8dd0eba7e89f46c3,

title = "Safety and efficacy of rilpivirine-tenofovir-emtricitabine (Eviplera (R)) in hepatitis C-HIV coinfection",

author = "F. Cresswell and A. Gothard and M. Cevik and G. Haidari and H. Alexander and I. Katsarolis and T. McGinty and A. Wolujewic and C. Saxon and M. Phillips and L. Hedley and N. Brima and N. Marshall and L. Swaden and J. Thornhill and \{de Ruiter\}, A. and R. Nandwani and P. Mallon and M. Chaponda and D. Churchill and M. Kingston and A. Ustianowski and L. Waters and C. Orkin and C. Smith and M. Nelson",

year = "2013",

language = "English",

volume = "18",

pages = "A61--A61",

journal = "Antiviral therapy",

issn = "1359-6535",

publisher = "Sage",

note = "15th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV ; Conference date: 15-10-2013 Through 17-10-2013",

}

Cresswell, F, Gothard, A, Cevik, M, Haidari, G, Alexander, H, Katsarolis, I, McGinty, T, Wolujewic, A, Saxon, C, Phillips, M, Hedley, L, Brima, N, Marshall, N, Swaden, L, Thornhill, J, de Ruiter, A, Nandwani, R, Mallon, P, Chaponda, M, Churchill, D, Kingston, M, Ustianowski, A, Waters, L, Orkin, C, Smith, C & Nelson, M 2013, 'Safety and efficacy of rilpivirine-tenofovir-emtricitabine (Eviplera (R)) in hepatitis C-HIV coinfection', Antiviral therapy, vol. 18, pp. A61-A61.

TY - JOUR

T1 - Safety and efficacy of rilpivirine-tenofovir-emtricitabine (Eviplera (R)) in hepatitis C-HIV coinfection

AU - Cresswell, F.

AU - Gothard, A.

AU - Cevik, M.

AU - Haidari, G.

AU - Alexander, H.

AU - Katsarolis, I.

AU - McGinty, T.

AU - Wolujewic, A.

AU - Saxon, C.

AU - Phillips, M.

AU - Hedley, L.

AU - Brima, N.

AU - Marshall, N.

AU - Swaden, L.

AU - Thornhill, J.

AU - de Ruiter, A.

AU - Nandwani, R.

AU - Mallon, P.

AU - Chaponda, M.

AU - Churchill, D.

AU - Kingston, M.

AU - Ustianowski, A.

AU - Waters, L.

AU - Orkin, C.

AU - Smith, C.

AU - Nelson, M.

PY - 2013

Y1 - 2013

M3 - Abstract

SN - 1359-6535

VL - 18

SP - A61-A61

JO - Antiviral therapy

JF - Antiviral therapy

T2 - 15th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV

Y2 - 15 October 2013 through 17 October 2013

ER -